Neural basis of major depressive disorder: Beyond monoamine hypothesis
- PMID: 28926161
- DOI: 10.1111/pcn.12604
Neural basis of major depressive disorder: Beyond monoamine hypothesis
Abstract
The monoamine hypothesis has been accepted as the most common hypothesis of major depressive disorder (MDD) for a long period because of its simplicity and understandability. Actually, most currently used antidepressants have been considered to act based on the monoamine hypothesis. However, an important problem of the monoamine hypothesis has been pointed out as follows: it fails to explain the latency of response to antidepressants. In addition, many patients with MDD have remained refractory to currently used antidepressants. Therefore, monoamine-alternate hypotheses are required to explain the latency of response to antidepressants. Such hypotheses have been expected to contribute to identifying hopeful new therapeutic targets for MDD. Past studies have revealed that the volume of the hippocampus is decreased in patients with MDD, which is likely caused by the failure of the hypothalamic-pituitary-adrenal axis and following elevation of glucocorticoids. Two hypotheses have been proposed to explain the volume of the hippocampus: (i) the neuroplasticity hypothesis; and (ii) the neurogenesis hypothesis. The neuroplasticity hypothesis explains how the hippocampal volume is decreased by the morphological changes of hippocampal neurons, such as the shortening length of dendrites and the decreased number and density of spines. The neurogenesis hypothesis explains how the hippocampal volume is decreased by the decrease of neurogenesis in the hippocampal dentate gyrus. These hypotheses are able to explain the latency of response to antidepressants. In this review, we first overview how the neuroplasticity and neurogenesis hypotheses have been developed. We then describe the details of these hypotheses.
Keywords: antidepressant; hippocampus; major depression; neurogenesis; neuroplasticity.
© 2017 The Authors. Psychiatry and Clinical Neurosciences © 2017 Japanese Society of Psychiatry and Neurology.
Similar articles
-
Investigating the relationship between hippocampus/dentate gyrus volume and hypothalamus metabolism in participants with major depressive disorder.Sci Rep. 2024 May 9;14(1):10622. doi: 10.1038/s41598-024-61519-z. Sci Rep. 2024. PMID: 38724691 Free PMC article. Clinical Trial.
-
Neurogenesis and antidepressant action.Cell Tissue Res. 2019 Jul;377(1):95-106. doi: 10.1007/s00441-019-03043-5. Epub 2019 Jun 4. Cell Tissue Res. 2019. PMID: 31165247 Review.
-
Liver X receptor β in the hippocampus: A potential novel target for the treatment of major depressive disorder?Neuropharmacology. 2018 Jun;135:514-528. doi: 10.1016/j.neuropharm.2018.04.014. Epub 2018 Apr 11. Neuropharmacology. 2018. PMID: 29654801
-
Hippocampal neuroplasticity in major depressive disorder.Neuroscience. 2015 Nov 19;309:200-13. doi: 10.1016/j.neuroscience.2015.04.047. Epub 2015 Apr 28. Neuroscience. 2015. PMID: 25934030 Review.
-
Despite higher glucocorticoid levels and stress responses in female rats, both sexes exhibit similar stress-induced changes in hippocampal neurogenesis.Behav Brain Res. 2012 Oct 1;234(2):357-64. doi: 10.1016/j.bbr.2012.07.011. Epub 2012 Jul 16. Behav Brain Res. 2012. PMID: 22814114
Cited by
-
St. John's wort extract Ze 117 alters the membrane fluidity of C6 glioma cells by influencing cellular cholesterol metabolism.Sci Rep. 2024 Apr 30;14(1):9878. doi: 10.1038/s41598-024-60562-0. Sci Rep. 2024. PMID: 38684848 Free PMC article.
-
Bupleurum in Treatment of Depression Disorder: A Comprehensive Review.Pharmaceuticals (Basel). 2024 Apr 16;17(4):512. doi: 10.3390/ph17040512. Pharmaceuticals (Basel). 2024. PMID: 38675471 Free PMC article. Review.
-
Shenyu ningshen tablet reduced neuronal damage in the hippocampus of chronic restraint stress model rat by inhibiting A1-reactive astrocytes.Heliyon. 2024 Apr 2;10(8):e28916. doi: 10.1016/j.heliyon.2024.e28916. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38655362 Free PMC article.
-
The association between gray matter volume in the hippocampal subfield and antidepressant efficacy mediated by abnormal dynamic functional connectivity.Sci Rep. 2024 Apr 18;14(1):8940. doi: 10.1038/s41598-024-56866-w. Sci Rep. 2024. PMID: 38637536 Free PMC article.
-
Review of research progress on intestinal microbiota based on metabolism and inflammation for depression.Arch Microbiol. 2024 Mar 10;206(4):146. doi: 10.1007/s00203-024-03866-z. Arch Microbiol. 2024. PMID: 38462572 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous